| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 6, 2021 | Odyssey Announces Agreement to Combine with BenevolentAI | LONDON and AMSTERDAM, Dec. 6, 2021 /PRNewswire/ -- Odyssey Acquisition S.A. ("Odyssey"), a Euronext Amsterdam-listed special-purpose acquisition company, and BenevolentAI, a leading clinical-stage AI drug discovery company, today ... |
| Dec 6, 2021 | Odyssey Announces Agreement to Combine with BenevolentAI | BenevolentAI is a leading, clinical-stage AI drug discovery company that combines advanced AI and machine learning with cutting edge science to discover and develop novel and more effective medicines
Combination of BenevolentAI with Odyssey... |
| Jul 9, 2021 | BenevolentAI : announces the appointment of biopharma luminary Dr François Nader as Chairman | LONDON, July 9, 2021 /PRNewswire/ -- BenevolentAI announces the appointment of Dr François Nader as Chairman.
Dr Nader is an experienced biopharma executive currently serving as Chairman of Talaris, Acceleron Pharma, independent Board Direc... |
| Apr 24, 2020 | Putting AI to work against COVID-19 | Putting AI to work against COVID-19
24-04-2020
Until the coronavirus pandemic took hold, it seemed that at least every other headline about healthcare innovations was related to machine learning or other forms of artificial intelligence (AI... |
| Apr 22, 2020 | How the Covid-19 pandemic has put the UK healthtech sector centre stage | The UK’s healthtech sector has rallied its world-class talent and skills to help in the fight against Covid-19. Startups and scaleups have found themselves working side by side with large-scale, global tech companies towards the common goal... |
| Apr 17, 2020 | COVID-19: A.I. Finds Potential Cure, Which Is Now Moving to Clinical Trials | Alec G., Tech Times 17 April 2020, 12:04 pm
A.I. might have found the potential cure for COVID-19, and it is already being tested in clinical trials.
(Photo : www.pexels.com)
Read More: Apple Online Store Down Amidst Preorders of New iPhone... |
| Apr 2, 2020 | UK tech companies tackling Covid-19 – from detection to vaccination | The 2020 Tech Nation Report revealed that UK healthtech investment has doubled since 2017, reaching £1.7bn in 2019. And this world-leading sector has just become more crucial than ever. Faced with a global pandemic, innovative scaling compa... |
| Mar 17, 2020 | Announcing: the UK companies joining Future Fifty 8.0 | Today we are delighted to welcome the new additions to our programme for late-stage tech companies. The prestigious Future Fifty.
The longest-running and most successful accelerator programme for late-stage tech companies in Europe, Future... |
| Nov 15, 2019 | King’s Cross is London’s Smartest Startups Tech Hub. Here’s What You Need to Know | 20 shares
Share
Tweet
Pin
LinkedIn
Once the ugly duckling of North London, King’s Cross has become a startup hub to rival any other: startups and tech giants alike are flocking to the area to do business.
King’s Cross: A New Global Kn... |
| Nov 11, 2019 | Investors just poured more than $1 billion into startups using AI to tackle every part of healthcare. Here are the 5 healthcare AI startups raking in the most cash. | Dr. Ali Parsa, the CEO of Babylon Health. Jack Lewis Williams for Tailor Made London This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
The deal count for VC-backed healthcare deals is on pa... |
| Nov 1, 2019 | AI will revolutionize drug discovery — but only if experts are involved | In health care, two exciting uses of artificial intelligence — in the clinic for patient care and in the laboratory for drug discovery — are remarkably different applications. That perhaps explains why, though it’s still early days for both... |
| Sep 18, 2019 | BenevolentAI draws $90M from Temasek amid reports of halved valuation | Days after news leaked that BenevolentAI had secured funding at a rate that would halve its $2 billion valuation, the machine learning startup officially announced it raised $90 million from Singapore-based Temasek for a... |
| Jul 24, 2019 | Could The NHS Really Sell Its Data For $12 Billion? | EY estimates that the value of the curated NHS dataset could be as much as £5 billion ($6.2 billion)... [+] per annum and deliver around £4.6 billion ($5.7 billoin) of benefit to patients per annum in potential operational savings for the N... |
| May 7, 2019 | Multi-million Pound Payday Could be on the Horizon for Exscientia Management | If the Exscientia flotation proceeds, Professor Andrew Hopkins could be in line for a huge payday. The Artificial Intelligence spin-off is reportedly contemplating an initial public offering and will be ready to float by May 2020.
Founded b... |
| Jan 3, 2019 | 10 European startups that raised mega-rounds of €100 million or more in 2018 | According to Atomico’s State of European Tech report, investment in European tech reached a record €20 billion in 2018 – up from just €4.3 billion in 2013. A clear sign of the maturation of the European tech startup ecosystem is the number ... |
| May 5, 2018 | AI researcher from Alphabet’s Calico Labs launches startup applying machine learning to drug discovery | To enable the machine learning, we will use high-quality data that has already been collected, but we will also invest heavily in the creation of our own datasets using high throughput experimental approaches, datasets that are designed exp... |
| Apr 20, 2018 | BenevolentAI gets $115M to harness AI for new drug discovery | BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States. Existing backer Woodford Investment Management also participated ... |
| Apr 20, 2018 | BenevolentAI raises $115 million to extend global position in AI enabled drug development | BenevolentAI raises $115 million to extend global position in AI enabled drug development
20-04-2018
BenevolentAI announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the... |
| Apr 19, 2018 | Term Sheet — Thursday April 19 | THE BITCOIN BANKRUPTCY THAT WASN’T
Good morning, Term Sheet readers. Jen Wieczner filling in for Polina today, to bring you the very twisty saga of a Bitcoin mystery. Find me on Twitter @jenwieczner or email me at [email protected].
... |
| Apr 19, 2018 | BenevolentAI Raises $115M in Funding | BenevolentAI, a London, UK-based AI pharmaceutical company, raised $115m in funding at a pre-money valuation of $2 billion.
The majority of investors are from the United States, with the balance of raised funds coming from existing investor... |
| Apr 19, 2018 | Biotech unicorn's 'brain' attracts a $115M mega-round as investors embrace AI upstart | Artificial intelligence in drug development is still gaining momentum. Just ask BenevolentAI, which has brought in a new $115 million round for its technology that promises to process vast amounts of bioscience inform... |
| Apr 19, 2018 | ИИ-стартап по созданию лекарств оценили в $2 млрд | Отдел новостей 19 апреля 2018, 17:05 ИИ-стартап по созданию лекарств оценили в $2 млрд
Оставить комментарий |
| Apr 18, 2018 | BenevolentAI, which uses AI to develop drugs and energy solutions, nabs $115M at $2B valuation | In the ongoing race to build the best and smartest applications that tap into the advances of artificial intelligence, a startup out of London has raised a large round of funding to double down on solving persistent problems in areas like h... |
| Mar 26, 2018 | This is how AI will shape drug discovery | An oft-quoted statistic is that it takes 12 years and almost $2 billion dollars to bring an average drug to market. That is the raison d’être for the biotech VC industry, which saw $10 billion of capital invested in startups in 2017 alone, ... |
| Feb 22, 2018 | BenevolentAI acquires advanced Cambridge research facility | BenevolentAI acquires advanced Cambridge research facility
22-02-2018
BenevolentAI, one of the world’s largest private AI companies, today announced that it has acquired a state-of-the-art drug discovery and development facility on the Babr... |
| Aug 25, 2017 | Novartis recruits a global digital chief; Shire CFO jumps ship | ⇨ Novartis appointed Bertrand Bodson to be its new chief digital officer, with a guiding hand in the way that Novartis uses digital technology in everything from drug discovery and development to the way it interac... |
| Jun 11, 2017 | 50 компаний в области искусственного интеллекта, за которыми стоит следить Статьи редакции | Подборка от сайта KD Nuggets.
12 12 комментариев
42 981 просмотров
Продажи и CRM
InsideSales.com — платформа для роста продаж, использующая предиктивные самообучающиеся алгоритмы. Компания привлекла более $251 млн инвестиций.
Persado — сис... |
| Mar 16, 2017 | Advances in AI and ML are reshaping healthcare | Megh Gupta Contributor
Megh Gupta is a member of the investment team at OMERS Ventures.
Qasim Mohammad Contributor
Qasim Mohammad is a Toronto-based venture capitalist and a member of the investment team at OMERS Ventures.
More posts by thi... |
| Dec 6, 2016 | BenevolentBio’s artificial intelligence could discover a better treatment for ALS | What if the drug that could effectively treat amyotrophic lateral sclerosis, the paralyzing neurological disease that skyrocketed into the public consciousness thanks to the ice bucket challenge, already exists?
That’s the question confront... |
| Oct 26, 2016 | Announcing the TechCrunch Disrupt London 2016 Agenda | TechCrunch Disrupt London returns to London in just a few weeks and we’re excited to reveal the agenda. We have an incredible lineup with global product launches, incredible speakers, engaging demos and the clash of ideas about the future o... |
| Oct 7, 2016 | Bioscience meets AI — Dr. Jackie Hunter of BenevolentAI to speak at Disrupt London | Disrupt hits London December 5-6 and it is our pleasure to announce that Dr. Jackie Hunter, Board Director of BenevolentAI and CEO of BenevolentBio, will be joining us as one of our featured speakers.
Dr. Jackie Hunter leads BenevolentAI, a... |
| AI researcher from Alphabet’s Calico Labs launches startup applying machine learning to drug discovery | A former Stanford University researcher who served as chief computing officer at Alphabet anti-aging business Calico Labs has launched a startup of her own. In a Medium blog post, Daphne Koller offered an overview of her new business, insit... |
| Robot nutrition, AI drug discovery, and neuro-rehabilitation: 11 of the most exciting healthcare startups in Europe | The Elvie Pump (pictured) is a portable, wearable breast pump. Elvie
The European digital health industry is booming.
$3.6 billion was invested in health-related tech firms in Europe between January and September 2019, according to an Atomi... |
| This is how AI will shape drug discovery | As healthcare venture capitalists, we specialize in technologies that have the potential to transform large markets in healthcare. Earlier this year, we predicted that 2018 would be a year of venture and M&A activity across the pharma v... |